- Home
- Publications
- Publication Search
- Publication Details
Title
Current pharmacotherapy options for cancer anorexia and cachexia
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 13, Issue 17, Pages 2453-2472
Publisher
Informa Healthcare
Online
2012-10-17
DOI
10.1517/14656566.2012.734297
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I pilot study of the safety and tolerability of olanzapine (OZA) for the treatment of cachexia in patients with advanced cancer
- (2017) F. Braiteh et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of GTx-024, a selective androgen receptor modulator (SARM), on physical function in patients with non-small cell lung cancer (NSCLC) with cancer cachexia.
- (2017) M. S. Steiner et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide in solid tumor patients with inflammatory cancer cachexia: A multicenter, randomized, double-blind, proof-of-concept study of fixed dose or CRP-response-guided dose or placebo.
- (2017) F. Strasser et al. JOURNAL OF CLINICAL ONCOLOGY
- Is there a role for parenteral nutrition or hydration at the end of life?
- (2013) Rony Dev et al. Current Opinion in Supportive and Palliative Care
- The role of the endocannabinoid system in eating disorders
- (2012) Eva M. Marco et al. BEHAVIOURAL PHARMACOLOGY
- Myostatin is a novel tumoral factor that induces cancer cachexia
- (2012) Sudarsanareddy Lokireddy et al. BIOCHEMICAL JOURNAL
- The 2011 ESPEN Arvid Wretlind lecture: Cancer cachexia: The potential impact of translational research on patient-focused outcomes
- (2012) K.C.H. Fearon CLINICAL NUTRITION
- Cachexia and Oxidative Stress in Cancer: An Innovative Therapeutic Management
- (2012) Giovanni Mantovani et al. CURRENT PHARMACEUTICAL DESIGN
- Inflammation and ovarian cancer
- (2012) Antonio Macciò et al. CYTOKINE
- Pilot Randomized Controlled Trial of Individual Meaning-Centered Psychotherapy for Patients With Advanced Cancer
- (2012) William Breitbart et al. JOURNAL OF CLINICAL ONCOLOGY
- Addressing Spirituality Within the Care of Patients at the End of Life: Perspectives of Patients With Advanced Cancer, Oncologists, and Oncology Nurses
- (2012) Andrea C. Phelps et al. JOURNAL OF CLINICAL ONCOLOGY
- Turning Toward Dissonance: Lessons From Art, Music, and Literature
- (2012) Suzana K.E. Makowski et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial
- (2012) Matthias Kraft et al. Nutrition Journal
- Free radicals and antioxidants: updating a personal view
- (2012) Barry Halliwell NUTRITION REVIEWS
- Influence of eicosapentaenoic acid supplementation on lean body mass in cancer cachexia
- (2011) R A Murphy et al. BRITISH JOURNAL OF CANCER
- Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
- (2011) Clelia Madeddu et al. CLINICAL NUTRITION
- Nutritional Interventions for Cancer-Induced Cachexia
- (2011) Norleena P. Gullett et al. CURRENT PROBLEMS IN CANCER
- Anti-inflammatory therapies in cancer cachexia
- (2011) Josep M. Argilés et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Role of nuclear factor-κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents
- (2011) Subash C Gupta et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer
- (2011) Trevor J Bayliss et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A randomized phase III clinical trial of a combined treatment for cachexia in patients with gynecological cancers: Evaluating the impact on metabolic and inflammatory profiles and quality of life
- (2011) Antonio Macciò et al. GYNECOLOGIC ONCOLOGY
- Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial
- (2011) Harvey Max Chochinov et al. LANCET ONCOLOGY
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- A systematic review on the role of fish oil for the treatment of cachexia in advanced cancer: An EPCRC cachexia guidelines project
- (2011) Anke Ries et al. PALLIATIVE MEDICINE
- Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trial
- (2011) Byeongsang Oh et al. SUPPORTIVE CARE IN CANCER
- Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia
- (2011) Katja Trobec et al. Journal of Cachexia Sarcopenia and Muscle
- Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting
- (2010) Norleena P Gullett et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Nausea and Vomiting in Advanced Cancer
- (2010) Sik Kim Ang et al. American Journal of Hospice & Palliative Medicine
- Muscle Wasting in Cancer Cachexia: Clinical Implications, Diagnosis, and Emerging Treatment Strategies
- (2010) Shontelle Dodson et al. Annual Review of Medicine
- Review: Energy regulation and neuroendocrine-immune control in chronic inflammatory diseases
- (2010) R. H. Straub et al. JOURNAL OF INTERNAL MEDICINE
- Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia
- (2010) G. Mantovani et al. ONCOLOGIST
- Efficacy and Safety of Oral Lactoferrin Supplementation in Combination with rHuEPO- for the Treatment of Anemia in Advanced Cancer Patients Undergoing Chemotherapy: Open-Label, Randomized Controlled Study
- (2010) A. Maccio et al. ONCOLOGIST
- More Is Better: A Multimodality Approach to Cancer Cachexia
- (2010) E. Del Fabbro ONCOLOGIST
- ESPEN Guidelines on Parenteral Nutrition: Non-surgical oncology
- (2009) F. Bozzetti et al. CLINICAL NUTRITION
- Medroxyprogesterone acetate in the management of cancer cachexia
- (2009) Clelia Madeddu et al. EXPERT OPINION ON PHARMACOTHERAPY
- Hypothalamic inflammation and energy homeostasis: Resolving the paradox
- (2009) Joshua P. Thaler et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
- (2009) Giovanni Mantovani et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
- (2009) Aminah Jatoi et al. LUNG CANCER
- Mechanisms of Cancer Cachexia
- (2009) Michael J. Tisdale PHYSIOLOGICAL REVIEWS
- The role of cytokines in cancer cachexia
- (2009) Josep M Argilés et al. Current Opinion in Supportive and Palliative Care
- Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study
- (2008) F Strasser et al. BRITISH JOURNAL OF CANCER
- Cachexia: A new definition
- (2008) William J. Evans et al. CLINICAL NUTRITION
- Cancer cachexia: Developing multimodal therapy for a multidimensional problem
- (2008) K.C.H. Fearon EUROPEAN JOURNAL OF CANCER
- Interleukin-6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients
- (2008) Antonio Macciò et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Emergence of ghrelin as a treatment for cachexia syndromes
- (2008) Mark Daniel DeBoer NUTRITION
- A randomized, double-blind, placebo-controlled trial of a β-hydroxyl β-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122)
- (2008) Lawrence Berk et al. SUPPORTIVE CARE IN CANCER
- Nutritional support in multimodal therapy for cancer cachexia
- (2008) Ingvar Bosaeus SUPPORTIVE CARE IN CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More